Clinical Trial Update: A Prospective Clinical Cohort Study on Stratified Treatment of Rhabdomyosarcoma Based on Risk Factors. [Phase 3]

View source ↗

Summary

A Phase 3 prospective cohort trial is evaluating risk-factor-based, stratified treatment for rhabdomyosarcoma and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhabdomyosarcoma

Snippet

Sponsor: Yizhuo Zhang | Conditions: Rhabdomyosarcoma, Pediatric Cancer | Phase 3 | Status: RECRUITING